Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

被引:11
|
作者
Poynter, Jenny N. [1 ,2 ]
Langholz, Bryan [2 ]
Largent, Joan [3 ]
Mellemkjaer, Lene [4 ]
Bernstein, Leslie [5 ]
Malone, Kathleen E. [6 ]
Lynch, Charles F. [7 ]
Borg, Ake [8 ]
Concannon, Patrick [9 ,10 ]
Teraoka, Sharon N. [9 ,10 ]
Xue, Shanyan [2 ]
Diep, Anh T. [2 ]
Torngren, Therese [8 ]
Begg, Colin B. [11 ]
Capanu, Marinela [11 ]
Haile, Robert W. [2 ]
Bernstein, Jonine L. [11 ]
机构
[1] Univ Minnesota, Div Pediat Epidemiol & Clin Res, Minneapolis, MN 55455 USA
[2] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[3] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
[4] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark
[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA
[6] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[7] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[8] Lund Univ, Dept Oncol, Lund, Sweden
[9] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA
[10] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA
[11] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Contralateral breast cancer; BRCA1; BRCA2; Reproductive factors; ESTROGEN-RECEPTOR; AGE; CARRIERS; PHENOTYPE; MENARCHE; COHORT; WOMEN; GENE;
D O I
10.1007/s10552-010-9510-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reproductive factors, such as early age at menarche, late age at menopause, and nulliparity are known risk factors for breast cancer. Previously, we reported these factors to be associated with risk of developing contralateral breast cancer (CBC). In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers. The WECARE Study is a population-based multi-center case-control study of 705 women with CBC (cases) and 1,397 women with unilateral breast cancer (controls). All participants were screened for BRCA1/2 mutations and 181 carriers were identified. Conditional logistic regression models were used to evaluate associations between reproductive factors and CBC for mutation carriers and non-carriers. None of the associations between reproductive factors and CBC risk differed between mutation carriers and non-carriers. The increase in risk with younger age at menarche and decrease in risk in women with more than two full-term pregnancies seen in non-carriers were not significantly different in carriers (adjusted RRs = 1.31, 95% CI 0.65-2.65 and 0.53, 95% CI 0.19-1.51, respectively). No significant associations between the other reproductive factors and CBC risk were observed in mutation carriers or non-carriers. For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers. This suggests that reproductive variables that affect CBC risk may have similar effects in mutation carriers and non-carriers.
引用
收藏
页码:839 / 846
页数:8
相关论文
共 50 条
  • [21] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [22] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
  • [23] Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study
    Giannakeas, Vasily
    Lubinski, Jan
    Gronwald, Jacek
    Moller, Pal
    Armel, Susan
    Lynch, Henry T.
    Foulkes, William D.
    Kim-Sing, Charmaine
    Singer, Christian
    Neuhausen, Susan L.
    Friedman, Eitan
    Tung, Nadine
    Senter, Leigha
    Sun, Ping
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 113 - 118
  • [24] Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence
    Shah, P.
    Rosen, M.
    Stopfer, J.
    Siegfried, J.
    Kaltman, R.
    Mason, B.
    Armstrong, K.
    Nathanson, K. L.
    Schnall, M.
    Domchek, S. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 539 - 546
  • [25] Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Cybulski, Cezary
    Lubinski, Jan
    Huzarski, Tomasz
    Lynch, Henry T.
    Randall, Susan Armel
    Neuhausen, Susan L.
    Senter, Leigha
    Friedman, Susan
    Ainsworth, Peter
    Singer, Christian
    Foulkes, William D.
    Narod, Steven A.
    Sun, Ping
    Kotsopoulos, Joanne
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (02) : 435 - 441
  • [26] Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
    Lee, Y. C.
    Milne, R. L.
    Lheureux, S.
    Friedlander, M.
    McLachlan, S. A.
    Martin, K. L.
    Bernardini, M. Q.
    Smith, C.
    Picken, S.
    Nesci, S.
    Hopper, J. L.
    Phillips, K. A.
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 114 - 120
  • [27] Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
    Pujol, Pascal
    Yauy, Kevin
    Coffy, Amandine
    Duforet-Frebourg, Nicolas
    Gabteni, Sana
    Daures, Jean-Pierre
    Penault Llorca, Frederique
    Thomas, Frederic
    Hughes, Kevin
    Turnbull, Clare
    Galibert, Virginie
    Rideau, Chloe
    Corsini, Carole
    Collet, Laetitia
    You, Benoit
    Genevieve, David
    Philippe, Nicolas
    CANCERS, 2022, 14 (13)
  • [28] Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Lynch, Henry T.
    Kim-Sing, Charmaine
    Neuhausen, Susan
    Demsky, Rochelle
    Foulkes, William D.
    Ghadirian, Parviz
    Tung, Nadine
    Ainsworth, Peter
    Senter, Leigha
    Karlan, Beth
    Eisen, Andrea
    Eng, Charis
    Weitzel, Jeffrey
    Gilchrist, Dawna M.
    Blum, Joanne L.
    Zakalik, Dana
    Singer, Christian
    Fallen, Taya
    Ginsburg, Ophira
    Huzarski, Tomasz
    Sun, Ping
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (07) : 1089 - 1096
  • [29] Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study
    Sisti, Julia S.
    Bernstein, Jonine L.
    Lynch, Charles F.
    Reiner, Anne S.
    Mellemkjaer, Lene
    Brooks, Jennifer D.
    Knight, Julia A.
    Bernstein, Leslie
    Malone, Kathleen E.
    Woods, Meghan
    Liang, Xiaolin
    John, Esther M.
    SPRINGERPLUS, 2015, 4 : 1 - 11
  • [30] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74